ELAB vs VRTX: Which Stock is Better?
Side-by-side comparison of Pmgc Holdings Inc and Vertex Pharmaceuticals Inc in 2026
ELAB
Pmgc Holdings Inc
$1.78
VRTX
Vertex Pharmaceuticals Inc
$435.93
Key Metrics Comparison
| Metric | ELAB | VRTX | Winner |
|---|---|---|---|
| Market Cap | $8.09M | $110.28B | VRTX |
| P/E Ratio | N/A | 25.77 | VRTX |
| EPS (TTM) | $N/A | $16.86 | VRTX |
| Revenue Growth | -0.5% | 0.1% | VRTX |
| Gross Margin | -63.1% | 54.4% | VRTX |
Analyze ELAB
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ELAB or VRTX a better investment?
Comparing ELAB and VRTX: Pmgc Holdings Inc has a market cap of $8.09M while Vertex Pharmaceuticals Inc has $110.28B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ELAB and VRTX?
ELAB (Pmgc Holdings Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ELAB or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ELAB or VRTX?
VRTX has higher revenue growth at 0.1% vs -0.5% for ELAB.
Which company is more profitable: ELAB or VRTX?
Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 54.4% compared to -63.1% for ELAB.
Which is the larger company: ELAB or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $110.28B compared to $8.09M for ELAB.
Should I buy ELAB or VRTX in 2026?
Both ELAB and VRTX have investment merit. ELAB trades at $1.78 while VRTX trades at $435.93. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ELAB and VRTX stock?
Key differences: Market Cap ($8.09M vs $110.28B), P/E Ratio (N/A vs 25.8x), Revenue Growth (-0.5% vs 0.1%), Gross Margin (-63.1% vs 54.4%).